Dr Mary Collins
University of Cambridge
A scientific symposium in collaboration with Fraunhofer IZI
30 September, 2026
Fraunhofer - IZI, Perlickstraße 1, 04103 Leipzig, Germany

Enter your information below to register
Seats are limited! Please register to secure your seat.
By attending, you confirm you are not located in or a national of a sanctioned country or region, are not a restricted party, and acknowledge that this training may include content subject to U.S. and other export control and sanctions laws. Sharing the content, whether verbally, visually, electronically, or via screen-sharing during webinars must comply with these laws. Allowing unauthorized or restricted individuals to view or participate is a violation and may result in civil and/or criminal penalties.
Advancing cell therapy: From science to manufacturing
Join leading scientists, researchers, and technology experts for a day dedicated to the latest innovations shaping the future of cell therapies.
This symposium will bring together experts from academia, clinical research, Fraunhofer IZI, and Cytiva to explore scientific advances across cell engineering, genomic medicine, gene editing, and emerging therapeutic platforms.
Together, Fraunhofer IZI and Cytiva empower the journey from discovery to patient impact.
Fraunhofer IZI is a trusted CRO & CDMO that brings expertise in clinical translation and advanced therapy manufacturing, while Cytiva delivers technologies, process knowledge, and scalable solutions enabling successful therapy development from clinical to commercial manufacturing.
Through a combination of presentations, scientific discussions, and practical demonstrations, you will gain valuable insights into the technologies supporting the next generation of advanced therapies.
What to expect:

This scientific symposium is organized in collaboration with Fraunhofer IZI
Agenda and schedules are subject to change. All times listed are in CEST.
| Time | Details |
|---|---|
| 9:00 – 9:30 | Registration |
| 9:30 – 9:45 | Welcome introduction |
| 9:45 – 10:15 | Mariangela Manicone (Scientific Affairs, Cytiva) Cell therapy at an inflection point |
| 10:15 – 10:45 | Anna Dünkel (Group Leader Process Development, Fraunhofer IZI) GMP compliant upscaling of cell therapies |
| 10:45 –11:00 | Coffee break |
| 11:00 – 11:30 | Tim Steinfatt (Cell Therapy Field Application Scientist, Cytiva) Autologous CAR T cell therapy manufacturing |
| 11:30 – 12:30 | Hands-on Sefia™ platform I & institute tour I |
| 12:30 – 13:30 | Lunch and networking |
| 13:30 – 14:30 | Hands-on Sefia™ platform II & institute tour II |
| 14:30 – 15:00 | Speaker announced soon |
| 15:00 – 15:30 | Sandy Tretbar (Group Leader Cell and Molecular Biology Unit) Non-viral delivery for immune cell engineering |
| 15:30 – 16:00 | Coffee break |
| 16:00 – 16:30 | Edward Grahame (Nanomedicine Alliance Manager, Cytiva) An ionizable LNP platform for scalable in vivo CAR T cell engineering |
| 16:30 – 17:00 | Speaker announced soon |
Chief Technology Officer, Danaher
Vivamus hendrerit lectus sit amet rhoncus vestibulum. Quisque suscipit diam nec nunc vehicula mollis.
Nam blandit eleifend neque, id aliquam sem laoreet nec. Curabitur vitae maximus tellus. Ut pellentesque orci vitae nisi pharetra, non vestibulum nulla mattis. In hendrerit diam ut neque aliquam feugiat. Nulla rutrum sagittis nulla, vel tempor ipsum fermentum vitae. Curabitur venenatis semper lorem, ut pretium felis laoreet eget. In semper gravida tellus eu.